SPP1 and familial pancreatic carcinoma: These results indicated that overexpression of OPN and FOXM1 might play contributory roles in the carcinogenesis and progression of pancreatic cancer, suggesting that OPN and FOXM1 could be considered as alternative diagnostic and prognostic biomarkers in pancreatic cancer.